VivoSeq
Other

Stress Response

0

Pipeline Programs

1

Active Trials

1

Companies Involved

Stress Response is an early-stage landscape with 0 programs across 1 company. The most active players are CeNeRx BioPharma Inc..

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed8 · 57%
Unknown status3 · 21%
Withdrawn1 · 7%
Suspended1 · 7%
Recruiting1 · 7%

Trial Activity

14 trials

Lignocaine Nebulization for Attenuation of Intubation Stress Response
Unknown status··Phase 4·NCT04441073·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)